PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerUbiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancerHuman Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cellsIdentification of novel androgen-responsive genes by sequencing of LongSAGE librariesThe four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisWidespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaSpondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progressionA role for tumor protein TPD52 phosphorylation in endo-membrane trafficking during cytokinesisDefining aggressive prostate cancer using a 12-gene model.Overexpressed oncogenic tumor-self antigensGene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stabilityIncreased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.Identification of gene expression signature in estrogen receptor positive breast carcinoma.Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage.Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident protein.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer riskHER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity.Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells.Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of ChondrocytesA novel experimental hypoxia chamber for cell culture.PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
P2860
Q21202034-83963995-D6CE-4EBE-B3D6-4371FF6BBB0FQ28266601-266D3D71-E67F-40AE-A608-456A12DA7E93Q28276911-06C110B6-16E8-43DB-91AF-5F4C6A9BA038Q30875945-1513341A-008C-49C3-A122-2A0737A9CE18Q33745941-BD5C3602-C400-480B-B5CD-4F0ED09224A9Q33911898-E279B17C-9432-4CDA-8FCA-0FE9AC3ABF82Q34276511-C51A3F77-5FF4-452F-B267-06258EC52F69Q34374537-0A7609EA-C88E-4AED-8E42-BA56FAEA2680Q34517584-AFC47B7F-6B13-4688-873B-A4DB28EEE09BQ35060298-87AF9E64-8DCF-4C57-B1B7-645268FC4757Q35886756-AFE8A095-31B2-4560-B2D6-04F204B2CFECQ36258513-0A7633BC-F346-4144-9E4B-32397DA42FFBQ36299687-C9D67308-8BC4-4CA9-8E4F-7CFF74F6F58DQ36587631-036C1485-7C5D-46A1-A070-6130B887E321Q36923290-2D62C6C0-023A-4A66-9A6B-E64AAA6700D8Q37195269-6136B5D6-F61D-45C6-900E-FCB218C2AA91Q37198099-5262B8E6-E2BD-4DE1-B7CB-487D47A3D0C3Q37219890-9A9B6DCA-261B-4EC4-83EE-FC6137C439B8Q37238021-CEBEF458-C1C0-4995-A094-6AA75EDEB8AFQ37308114-24B475BE-3C60-4EEA-8E51-6DD350725AC4Q37582166-6E6836DD-98CC-4ABE-B318-E9ECB9E47F2BQ37641774-6090318D-37FC-451D-BDE0-F6E418C8635AQ37697163-BDC47A5C-5D75-4858-A519-ADC418407299Q38570271-B97FA241-4126-4A25-9BD0-C960C08E7F4AQ38796619-B620044D-98D8-4768-9E3D-5218CACE2DA1Q38823738-7C967AC3-1169-4192-9059-6A637AC4576FQ38880242-215ABAF5-1C09-4622-AA56-1E8105744AFBQ39001066-70B56D35-C655-40A7-A105-FAAB3E46F8FAQ39585352-11392635-B5BA-47D7-A48F-517519172A28Q39803368-1F696918-6A36-4523-BC02-E280BA26426DQ39923830-FC12CF73-EC2E-4EA8-B4A1-3C12D587CFB1Q40200300-121F0204-0E05-44D4-B08A-47C08C4E1BB9Q41180083-FF42850D-57BF-4EA4-A8D1-021D9BEB1006Q41891575-5836D9CD-92D1-4C15-A75F-37AF03E1D1E8Q47139658-4FD63A5C-B35A-4420-9806-28280328985EQ54441612-BAE13AD1-CF5D-4354-835C-6E7079E2475F
P2860
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@ast
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@en
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@nl
type
label
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@ast
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@en
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@nl
prefLabel
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@ast
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@en
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@nl
P2093
P50
P3181
P1433
P1476
PrLZ, a novel prostate-specifi ...... essed in human prostate cancer
@en
P2093
Fray F Marshall
Haiyen E Zhau
Jianchun Xu
Jianguang Zhou
John A Petros
Leland W K Chung
Mahul Amin
Nicola Mabjeesh
Peter S Nelson
P304
P3181
P356
10.1158/0008-5472.CAN-03-3331
P407
P577
2004-03-01T00:00:00Z